IDEXX Laboratories to Release 2024 Third Quarter Financial Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has announced the upcoming release of its 2024 third quarter financial results. The results will be made public on Thursday, October 31, 2024, before the market opens. Following the release, the company will host an analyst conference call at 8:30 a.m. EDT on the same day.
Investors and interested parties can access a live webcast of the conference call, along with a transcript of prepared remarks and the Q3 2024 Earnings Snapshot, through the IDEXX website at www.idexx.com/investors. An archived version of the webcast will be available after 1:00 p.m. ET and remain accessible for one year. For those preferring to listen via telephone, the call can be accessed by dialing 1-800-289-0462 or 1-323-794-2442 and using the passcode 205740.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), leader globale nell'innovazione della salute degli animali domestici, ha annunciato la prossima pubblicazione dei risultati finanziari del terzo trimestre 2024. I risultati saranno resi pubblici giovedì 31 ottobre 2024, prima dell'apertura del mercato. Dopo la pubblicazione, l'azienda ospiterà una conference call per analisti alle 8:30 EDT dello stesso giorno.
Investitori e parti interessate possono accedere a un webcast live della conference call, insieme a una trascrizione delle dichiarazioni preparate e allo Snapshot degli utili del Q3 2024, attraverso il sito web di IDEXX all'indirizzo www.idexx.com/investors. Una versione archiviata del webcast sarà disponibile dopo le 13:00 ET e rimarrà accessibile per un anno. Per coloro che preferiscono ascoltare tramite telefono, la chiamata può essere accessibile componendo 1-800-289-0462 o 1-323-794-2442 e utilizzando il codice di accesso 205740.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), líder global en innovación en salud para mascotas, ha anunciado la próxima publicación de sus resultados financieros del tercer trimestre de 2024. Los resultados se harán públicos el jueves 31 de octubre de 2024, antes de la apertura del mercado. Después de la publicación, la compañía llevará a cabo una conferencia telefónica para analistas a las 8:30 a.m. EDT ese mismo día.
Los inversores y partes interesadas pueden acceder a un webcast en vivo de la llamada, junto con una transcripción de las declaraciones preparadas y el Snapshot de ganancias del Q3 2024, a través del sitio web de IDEXX en www.idexx.com/investors. Una versión grabada del webcast estará disponible después de la 1:00 p.m. ET y seguirá accesible durante un año. Para aquellos que prefieren escuchar por teléfono, se puede acceder a la llamada marcando 1-800-289-0462 o 1-323-794-2442 y usando el código de acceso 205740.
IDEXX Laboratories, Inc. (NASDAQ: IDXX)는 반려동물 건강 관리 혁신의 글로벌 선두주자로서 2024년 3분기 재무 결과 발표를 예고했습니다. 결과는 2024년 10월 31일 목요일, 시장 개장 전에 공개될 예정입니다. 발표 후, 회사는 같은 날 오전 8시 30분 EDT에 애널리스트 컨퍼런스 콜을 개최합니다.
투자자 및 관심 있는 당사자는 IDEXX 웹사이트 www.idexx.com/investors를 통해 준비된 발언 및 Q3 2024 수익 스냅샷의 전사와 함께 실시간 웹캐스트에 접속할 수 있습니다. 웹캐스트의 아카이브 버전은 오후 1시 이후에 이용 가능하며 1년 동안 접근할 수 있습니다. 전화로 듣기를 원하는 경우, 1-800-289-0462 또는 1-323-794-2442로 전화한 후 접속 코드 205740을 입력하면 됩니다.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), un leader mondial de l'innovation en santé animale, a annoncé la prochaine publication de ses résultats financiers du 3ème trimestre 2024. Les résultats seront rendus publics jeudi 31 octobre 2024, avant l'ouverture du marché. Après la publication, l'entreprise organisera une conférence téléphonique pour analystes à 8h30 EDT le même jour.
Les investisseurs et parties intéressées peuvent accéder à un webinaire en direct de la conférence, ainsi qu'à un compte rendu des déclarations préparées et au Snapshot des résultats du Q3 2024, via le site web d'IDEXX à l'adresse www.idexx.com/investors. Une version archivée du webinaire sera disponible après 13h00 ET et restera accessible pendant un an. Pour ceux qui préfèrent écouter par téléphone, la conférence peut être jointe en composant le 1-800-289-0462 ou le 1-323-794-2442, en utilisant le code d'accès 205740.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), ein globaler Marktführer in der Innovation im Bereich Haustiergesundheit, hat die bevorstehende Veröffentlichung seiner finanziellen Ergebnisse für das 3. Quartal 2024 angekündigt. Die Ergebnisse werden am Donnerstag, den 31. Oktober 2024, vor Markteröffnung veröffentlicht. Nach der Veröffentlichung wird das Unternehmen am selben Tag um 8:30 Uhr EDT eine Analysten-Konferenzschaltung abhalten.
Anleger und interessierte Parteien können über die IDEXX-Website www.idexx.com/investors auf ein Live-Webcast der Telefonkonferenz zugreifen, zusammen mit einem Transkript der vorbereiteten Aussagen und dem Q3 2024 Earnings Snapshot. Eine archivierte Version des Webcasts wird nach 13:00 Uhr ET verfügbar sein und ein Jahr lang zugänglich bleiben. Für diejenigen, die lieber telefonisch teilnehmen möchten, ist die Konferenz unter den Nummern 1-800-289-0462 oder 1-323-794-2442 mit dem Zugangscode 205740 erreichbar.
- None.
- None.
Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q3 2024 Earnings Snapshot through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the webcast will be available after 1:00 p.m. ET on that day via the same link and will remain available for one year.
The live call also will be accessible by telephone. To listen to the live conference call, please dial 1-800-289-0462 or 1-323-794-2442 and reference passcode 205740.
About IDEXX Laboratories, Inc.
IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500® Index. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240930530832/en/
Investor Relations
investorrelations@idexx.com
Source: IDEXX Laboratories, Inc.
FAQ
When will IDEXX Laboratories (IDXX) release its Q3 2024 financial results?
What time is the IDXX Q3 2024 earnings conference call scheduled for?
How can investors access IDEXX's (IDXX) Q3 2024 earnings webcast and materials?
What are the dial-in details for IDEXX's (IDXX) Q3 2024 earnings call?
